chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reports onset of facial and eyelid swelling within hours of administration of COVID vaccine number one.  She also reports some increased work of breathing and some discomfort in her throat.  She did not have to administer an Epi-Pen but did take oral benadryl.  The morning after the vaccine- facial swelling had increased- but was gradually improving as the hours progressed.  No breathing difficulty or throat concerns reported by the next day at the clinic visit.
pt inadvertently recv vax & devel a fever of 101 & vomiting;this event was reported directly to VAERS by the hlth care provider;
Patient received her 1st COVID vaccination - it was Pfizer. She then presented to our clinic for her 2nd dose and we gave her Moderna in error. We only offer Moderna at this site, the patient did not notice it was Moderna on our website or on the paperwork we provided and our nurse failed to notice patient's vaccine card said Pfizer for 1st dose.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medications were not reported. On 07-DEC-2018, the patient was vaccinated with VARIVAX (strength, dose, frequency, route, lot# and expiry were not reported) for prophylaxis, reconstituted with expired sterile diluent (strength, dose, frequency were not reported) lot #M019891 and expiry date reported 11-OCT-2018 and no adverse effects were reported. This is one of the 3 reports concerning same reporter.
Pt rec'd 3 vaccines in R thigh 9d later came to urgent care for swelling and erythema with central "boil". Tx'd for cellulitis with Septra and Rifampin. Pt also developed a eryth papular exantham on face which spread to body on day 11. Likely MMR Rash.
Patient had a cold after receiving their last dose a year ago; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Patient had a cold after receiving their last dose a year ago) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Patient had a cold after receiving their last dose a year ago). At the time of the report, NASOPHARYNGITIS (Patient had a cold after receiving their last dose a year ago) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
Moderna COVID-19 Vaccine EUA Red blotchiness/rash appeared on left arm around location of vaccination.  Mild itchiness associated with 2" diameter redness.
Excruciating spinal and back pain radiating over entire spine and towards flanks. Warmth along spine. I tried a massage and hot packs but they provided no relief, I laid on floor for two hours until I felt tired enough to sleep. I slept on floor. Advil helps a little, and I slept with pain during night. I awoke to a stiff back and slight back pain, but it was better than previous night. The pain lasted during the day and let up as the day progressed.
little pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little pain in the arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid activity decreased (less active thyroid) and Blood pressure.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little pain in the arm). At the time of the report, PAIN IN EXTREMITY (little pain in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were unspecified 0.5mcg thyroid medication for less active thyroid, Metabolic supplement multivitamin for twice, daily, not to get infections/inflammations natural products. regulates blood pressure. The treatment information was unknown. Patient got 2 shots of the Moderna vaccine already and has an appointment to get the booster dose next Monday.   This case was linked to MOD-2021-385764 (Patient Link).
Information has been received from a nurse practitioner concerning a 24 year old female patient with no known allergies or pertinent medical history, who on 13-JAN-2010 was vaccinated with the first dose of GARDASIL (lot number and route not reported). Concomitant therapy included hormonal contraceptives (unspecified). On approximately 13-JAN-2010 "within 24 hours after vaccination", the patient experienced severe headache and hearing loss for 5 hours. On approximately 13-JAN-2010, the patient went to the emergency room. On 14-JAN-2010 the patient recovered from the severe headache and the hearing loss. No tests or studies were performed. Upon internal review, the hearing loss was considered to be an other important medical event. Additional information has been requested.
after first shot i notice sunburn and blistering on the top shoulder of injection site arm. second dose i received in the opposite arm. a few hours after injection my entire face turned red and itchy. it has been a week and i am less red but my face is still itchy. my right cheek had gotten very hot and red and now the skin is peeling like it was burned.
Woke up on fifth day post inj with red, raised area on left temple that was painful to the touch. Extended onto scalp. Applied various topical medications with no relief. Scalp improved in about a week. Rah still visible on temple.
I developed a very painful spot on my left side where my bra was sitting. It started as a small bump but developed into a rash that wrapped from my left side to my lower back. I saw the Dr. in early April who diagnosed it as Shingles and they put me on valacyclovir.
Horrible tinnitus with very bad neck pain; Horrible tinnitus with very bad neck pain; Tension headaches; vision issues; This is a spontaneous report from a contactable consumer (patient). A 47-years-old male patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EN6202 and Expiration date was not reported), via an unspecified route of administration, administered in left arm on 07Mar2021 at 14:45 hours as dose 2, single (at the age of 47-years-old) for covid-19 immunization. Medical history included known allergy to penicillin from an unknown date and unknown if ongoing and had no other medical history. Patient previously received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: ELG9266 and Expiration date was not reported), via an unspecified route of administration, in left arm on 14Feb2021 at 14:00 hours as dose 1, single (at the age of 47-years-old) for covid-19 immunization. Patient did not receive any other medications the patient received within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior to vaccination. Patient had not been tested for COVID-19, since the vaccination. On 21Mar2021 at 19:00 hours, patient experienced horrible tinnitus with very bad neck pain, tension headaches and vision issues. Patient had doctor or other healthcare professional office/clinic and emergency room/department or urgent care visit for the events. Patient had various ongoing treatments for all the events. The events were reported as non-serious as per the reporter. The outcome of all the events was not recovered.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Nov2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 29 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient had no known allergies. Patient had levothyroxine in 2 weeks. Patient received anti-viral treatment with Paxlovid from 06Dec2022 to 11Dec2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Severe headache with nausea and chills 3.5 hours after dose. Muscle spasms and cramping,  fever that evening. Day two continued with headache and fever along with generalized ache/pain to muscles and skin.
This spontaneous report was received from a physician via an unspecified reporter referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 23-NOV-2015, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 PK 0.5mL SD-PFS LLokwTip 10 PK" and lot number L014876 with expiration date of 13-JAN-2017 (route of administration and anatomical location were not reported), which was stored at a lowest recorded temperature of 27F (-2.777777778 Celsius) for 504 hours. The vaccine status was reported as excursion and the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Initial unsolicited case received from a physician on 11 Oct 2017. This case involves a male patient (age not reported) who was vaccinated with 0.5 ml single dose of FLUZONE QUADRIVALENT (Batch number, expiry date, dose in series and site of administration was not reported) via intramuscularly on an unspecified date (reported as several years ago) for immunization. Patient's medical history and concomitant medications were not reported. On an unknown date, post vaccination, patient had gastrointestinal symptoms such as nausea and diarrhea. Lab tests and corrective treatment was not reported. On an unknown date, Patient was recovered from all events. List of documents held by sender: none.
I went to the doctor on Thursday 11/10/2022 because I had fever, chills, shortness of breath, cough, body aches. I was tested for COVID-19, Influenza A and B. The test for COVID-19, Influenza B came back negative but the test for Influenza A came back positive. I was given a prescription for Tamiflu for and cough medication. By Saturday I could not breath and was gasping for air. I went to an Urgent Care thinking I was getting pneumonia. They ran an EKG that came back abnormal and sent me to the hospital and had me admitted, I have pericarditis.
Information has been received from a consumer concerning to his daughter who on 27-JUN-2008 was vaccinated with 0.5 ml of GARDASIL vaccine (yeast) (batch and lot numbers not reported) intramuscular. Concomitant therapy included PROZAC and CLONOPIN. About a week after she got the vaccine (on approximately 04-JUL-2008) the patient experienced stomach pain and muscle weakness. The patient had blood work done (results not reported). The patient was recovering from stomach pain and muscle weakness. Additional information has been requested.
This case was reported by a consumer via Online and described the occurrence of possible pulmonary hypertension in a female patient who received VENTOLIN for an unknown drug indication. A physician or other health care professional has not verified this report. On an unknown date, the patient started salbutamol sulphate (unknown) at unknown dosing. At an unknown time after starting salbutamol sulphate, the patient saw a new pulmonologist, who told her she might have pulmonary hypertension. This case was assessed as medically serious by GSK. At the time of reporting, the outcome of the event was unknown, and the patient was waiting for the completion of unspecified tests. Information was received on 15 February 2013 via monitoring of GSK website. The patient was taking VENTOLIN HFA but start date and dosing was not provided. She reported she "usually has mild side effects that go away with time." She had started a new medication really "did not realize that my labored breathing could have been from that medication. She just thought her COPD was just bad that day." COPD was concurrent medical condition. No other details provided. Follow-up information was received on 26 March 2013 via monitoring of GSK website. While on salbutamol sulphate, the patient experienced bloating, her stomach hurting and trouble breathing. She also reported having diverticulitis (onset date in relation to salbutamol sulphate use was not provided). The patient stated that her physician thought diverticulitis was the reason for the bloating and stomach pain. Follow-up information was received on 23 October 2013 from the patient via GSK Patient Market research Online Community (MROC). The patient was taking salbutamol sulphate for chronic obstructive pulmonary disease. The patient stated, "...while working around the house doing day to day chores I seemed to be having more and more trouble breathing (difficulty in breathing on exertion). At the time of reporting, the outcome of difficulty in breathing on exertion was unknown. Follow-up information was received on 22 October 2013 from the patient via GSK Patient Market Research Online Community (MROC). On an unspecified date in 2013 the subject received unspecified dose of influenza unspecified (unknown). Within months of vaccination with influenza unspecified, the subject experienced "some sort of reaction to my flu shot" (nonspecific reaction) and flu-like-illness. The subject stated "I have noticed this is the first year that I seemed to actually have some sort of reaction to my flu shot. I can only imagine if I had not got the shot how the flu would have knocked me out. I am so glad to get my shots and know that I will not get a full blown flu illness". At the time of reporting the outcome of the nonspecific reaction and flu-like-illness were unspecified.
Covid Arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Mar-2021 and was forwarded to Moderna on 13-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Covid Arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Covid Arm). At the time of the report, VACCINATION COMPLICATION (Covid Arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  The patient's daughter reported that her mother had Covid Arm following the vaccination, and did not want to provide any further details of the event without patient's consent.  Treatment details were not provided.
Felt as if I had severe arthritis in both areas and hands/fingers ... more pronounced in the left arm. Lasted through the night and into the next morning. Hurt to pick up my pillow. Very sore very tired but otherwise good
LOW GRADE FEVER, SWOLLEN GLANDS INITIALLY. PERICARDIAL EFFUSION (PERICARDITIS) LATER. 1.7 LITERS OF FLUID IN PERICARDIUM WHICH MAY HAVE DEVELOPED SLOWLY.
Vaccine was stored after expiration date in the refrigerator; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was stored after expiration date in the refrigerator) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.  Date vial placed in refrigerator was 04-Nov-2022. The vial did not underwent temperature excursion. Patient did not experience any adverse event.
The patient began experiencing a flushing feeling and headache approximately 30 minutes following the administration of the Moderna COVID-19 vaccine on 5.7.21, later on that day white blisters began to appear on her hands and feet along with severe joint pain. The patient took 3 ibuprofen and 1 percocet to combat the joint pain. When the patient went to bed she had a fever of 102 degrees. Upon waking the patient experienced full body paralysis and was then taken to the ER. Once administered to the ER, the patient stated that she was given 3 different antibiotics. Once the patient was moved to the floor where she had remained in the hospital for 7 days where she was given corticosteroids to combat the severe joint pain and pressure experienced between head and neck. The patient stated that she is scheduled to be on antibiotics for 3 months but her symptoms have resolved.
Patient presents to the emergency department with complaint of worsening cough and shortness of breath since Tuesday.  Patient was found to be hypoxic upon EMS arrival with pulse ox is 7 0% on room air, patient does not require oxygen at baseline.  Patient complains of generalized weakness, nausea, fever, cough, and shortness of breath.  Patient complains of generalized body aches, rates it 2 out of 10, nonradiating, no aggravating or relieving symptoms.
Patientt received first Moderna vaccine on 29MAR2021. 11 days later  - patient returned to receive his 2nd shot on 09APR2021. pt failed to show current covid card to screening medic. Pt also failed to fill out form correctly where it asked if he received a covid shot in the past. Pt answered "no". pt received shot and four days later found out he got his vaccine too early. He states he had no symptoms and felt fine the whole time.
About 530 AM on 4/26/08 patient was asleep, mother noted generalized shaking all over, staring off into space and arm stiffening.  Presented by EMS to ED, thought to be febrile seizure.
on 4JUL pt devel s/t, dry throat congestion; 5JUL devel mildly pruritic rash & body aches on upper body; seen by MD;
This was a booster, 8 months out from second dose of the Moderna vaccine. At about 12 hours after injection, I got up to get Tylenol. I was having trouble standing up and was very disorientated. My husband came to help me find the Tylenol. I turned to return to bed and then my husband heard me hit the floor (concrete floors in our bedroom). When he turned me over, I was limp, my eyes were open, but not focused on anything. Then I started coming to. I had split my chin open and had blood coming out of my ear. I didn't know what day it was nor when he told me, could I retain the information, and kept asking. I don't remember hitting the floor. He said I was face down with my arms at my side. I received stitches in my chin and mouth, had a scan of my head and an EKG of my heart. They found no fractures or broken bones. The brain scan came back fine as well.
A client received his first dose of MPX intradermally on 9/9/22 around 4:35pm. This individual does not have any medical history of heart disease besides acute asthma. He also has no hx of vaccine reactions in the past. After receiving the first dose of MPX on his left forearm, he felt some numbness on his left arm that radiated to the left side of his chest and felt like his heart was beating faster than normal. Per client, he felt some left sided chest tightness when he tried gripping his left hand, as well. Per client, he did not have SOB and nor difficulty breathing. The client did not exhibit any s/s of an allergic rxn and his vitals were normal. His vitals at 4:40pm were: BP R arm: 126/82; Pulse: 60bpm; O2: 99. I reassessed his vitals again at 4:54pm and they were: BP R arm: 126/80; O2: 99; Pulse: 60bpm. Around 4:50pm the client stated that the numbness was still present but gradually improving. His grip, per client, was stronger and easier to do. He felt comfortable heading back home by himself but was advised to seek medical care if the numbness worsens and other s/s such as SOB, difficulty breathing becomes present.
Patient received FLUZONE HIGH DOSE immunization in the pharmacy, was waiting on husband to get his and had passed out on bench while waiting. We reacted to the patient who was unresponsive but still breathing. Called 911. Patient become alert and was very warm. Pulse was solid. Pt did urinate in the process. EMS came and evaluated her. Patient denied need to go to hospital, but did wait on her daughter to come pick her up rather than drive home. Did test blood pressure and reported to both patient and daughter that is was very low, even a half hour after the incident (while waiting for daughter to come).
It was reported in a newspaper article that a 16 year old female patient on an unspecified date, was vaccinated with the second dose of GARDASIL. Subsequently the patient experienced a visual loss in the right eye and a left side headache. Over the next 24 hours, the patient's symptoms worsened to include her left eye and a more severe headache. Ten days after the second vaccine, the perfectly healthy patient was left almost totally blind. At the time of reporting, the outcome was unknown. The reporter stated that it was possible that human papilloma virus was the precipitant for the demyelinating event in the patient presented here. It was tempting to speculate whether there may be a specific immune mechanism initiated with human papilloma virus not yet identified, which resulted in not only acute demyelinating encephalomyelitis but also in an unusual clinical course that resulted in persistent visual loss. An expert who worked in the vaccine trials said that the majority of vaccine injuries actually occur in what she called the 'biologically plausible time frame' which was, she said, up to 42 days after the vaccine. Upon internal review, visual loss in the right eye and visual loss in the left eye were determined to be other important medical events. No further information is available.